Cohort Studymoderate evidence
Auto-regulated bioprosthetic total artificial heart as bridge to transplantation: the EFICAS study.
European heart journal·August 31, 2026·PMID 42670784
Why it mattersRefractory advanced biventricular heart failure has limited options when LVAD is contraindicated, and historical total artificial hearts carry high stroke and bleeding risks. This bioprosthetic TAH offers a potentially safer bridge to transplant for a high-acuity population.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled